The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB-Reference-Cited by-同舟云学术

The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB

Published:2015-12-18 Issue:17 Volume:7 Page:24848-24859
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Jieqiong¹²,Mao Kai³⁴,Jiang Shuai⁵,Jiang Wen⁶,Chen Kai¹²,Kim Betty Y.S.⁷,Liu Qiang¹,Jacobs Lisa K.²

Affiliation:

1. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

2. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA

3. Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of General Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China

4. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

5. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

6. Department of Radiation Oncology, MD Anderson Cancer Center, Houston, TX, USA

7. Department of Neurological Surgery, Mayo Clinic Florida, Jacksonville, FL, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is postmastectomy radiotherapy necessary for breast cancer patients with clinically node-positive downstaging to ypN0 after neoadjuvant chemotherapy?;Breast Cancer Research and Treatment;2024-04-15

2. Does Post-Mastectomy Radiotherapy Confer Survival Benefits on Patients With 1-3 Clinically Positive Lymph Nodes Rendered Pathologically Negative After Neoadjuvant Systemic Chemotherapy: Consensus from A Pooled Analysis?;European Journal of Breast Health;2024-04-01

3. Hype or hope? A review of challenges in balancing tumor control and treatment toxicity in breast cancer from the perspective of the radiation oncologist;Clinical and Translational Oncology;2023-07-28

4. Synchronous Bilateral Breast Cancer With Discordant Receptor Status: Treating One Patient but Two Diseases;World Journal of Oncology;2023-06

5. Established and new horizons in radiotherapy for breast cancer;Therapeutic Advances in Medical Oncology;2023-01